LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 92.98 | 84.90 | 2579 | 7257 | 0.3554 | 0.7022 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 94.68 | 84.90 | 27 | 7000 | 0.0039 | -0.1647 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 94.68 | 84.90 | 4138 | 7000 | 0.5911 | 0.8415 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 94.68 | 84.90 | 1 | 7000 | 0.0001 | -0.5023 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 94.68 | 84.90 | 1354 | 7000 | 0.1934 | 0.5451 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 2.66 | 84.90 | 456 | 285 | 1.5959 | 1.6120 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 2.66 | 84.90 | 435 | 285 | 1.5224 | 1.5426 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 2.66 | 84.90 | 640 | 285 | 2.2398 | 2.1699 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 4.36 | 84.90 | 630 | 322 | 1.9531 | 1.8313 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 4.36 | 84.90 | 540 | 322 | 1.6740 | 1.6135 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 4.36 | 84.90 | 681 | 322 | 2.1112 | 1.9481 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 6.06 | 84.90 | 748 | 365 | 2.0468 | 1.8102 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 6.06 | 84.90 | 618 | 365 | 1.6911 | 1.5667 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 6.06 | 84.90 | 796 | 365 | 2.1781 | 1.8945 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 7.77 | 84.90 | 824 | 411 | 2.0037 | 1.7142 | MN20160318_Q02 | H19 |